B Douglas Smith

Professor

1983 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where B Douglas Smith is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
alvocidib Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2019

Acute Promyelocytic Leukemia
Fibrinogen
Heparin
Hemorrhage

Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia

Cortes, J. E., Muresan, B., Mamolo, C., Cappelleri, J. C., Crescenzo, R. J., Su, Y., Gambacorti-Passerini, C., Heeg, B. & Smith, B. D., Jan 1 2019, In : Current Medical Research and Opinion.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Cytogenetics
Disease-Free Survival
Survival
Therapeutics

Side effects from acute myeloid leukemia treatment: results from a national survey

Crossnohere, N. L., Richardson, D. R., Reinhart, C., O’Donoghue, B., Love, S. M., Smith, B. D. & Bridges, J. F. P., Nov 2 2019, In : Current Medical Research and Opinion. 35, 11, p. 1965-1970 6 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Caregivers
Fatigue
Therapeutics
Poisons

The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia

Webster, J. & Smith, B. D., Jan 1 2019, (Accepted/In press) In : Clinical Therapeutics.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
United States Food and Drug Administration
Research
Randomized Controlled Trials
Disease Management